Table 4.

Results of univariable and final multivariable mixed model regressions of EQ-5D-3L index scores for the full population (n = 285)

	Univariable regression		Multivariable regression
	β (95% CI)	p-value	β (95% CI)	p-value
Constant	0.51 (0.39–0.10)	< 0.001	0.80 (0.39–1.20)	< 0.001
Intervention group	0.04 (−0.03–0.10)	0.293	0.007 (–)	0.791
Time (reference: discharge)
1 month	0.02 (−0.02–0.06)	0.396	0.02 (−0.02–0.06)	0.387
6 months	−0.01 (−0.06–0.03)	0.484	−0.02 (−0.06–0.03)	0.473
12 months	−0.06 (−0.10–−0.02)	0.003	−0.06 (−0.10–−0.02)	0.003
Study ward 1	−0.17 (−0.25–−0.09)	< 0.001	NS
Age when includeda	−0.01 (−0.02–−0.01)	< 0.001	−0.003 (0.155–)	0.229
Sex Female	−0.06 (−0.13–0.01)	0.114	NS
Level of education > 12 years	0.02 (−0.05–0.09)	0.612	NA
Home-dwelling before included	0.20 (0.07–0.34)	0.003	0.22 (0.11–0.33)	< 0.001
Living alone before included	−0.03 (−0.10–0.04)	0.380	NA
Home-care services	−0.26 (−0.32–−0.20)	< 0.001	−0.15 (−0.21–−0.08)	< 0.001
Number of medications totala	−0.03 (−0.03–−0.02)	< 0.001	−0.02 (−0.02–−0.01)	< 0.001
Handling own medications	0.25 (0.19–0.31)	< 0.001	NS	NS
Multidose adherence aid	−0.26 (−0.33–−0.19)	< 0.001	−0.11 (−0.18–−0.04)	< 0.001
Hypertension	0.005 (-0.07–0.06)	0.894	NA
Asthma or COPD	−0.09 (−0.16–−0.01)	0.021	NS
Atrial fibrillation	−0.04 (−0.11–0.04)	0.318	NA
Diabetes	−0.09 (−0.17–−0.00)	0.040	NS
Heart failure	−0.08 (−0.18–0.01)	0.086	NS
Renal failure	−0.02 (−0.12–0.07)	0.630	NA
Anxiety / depression	−0.15 (−0.27–−0.39)	0.009	NS
Dementia	−0.17 (−0.34–0.01)	0.059	NS
Charlson Comorbidity Indexb	−0.03 (−0.05–−0.02)	< 0.001	NS

COPD Chronic Obstructive Pulmonary Disease; CI confidence interval; β regression coefficient; NS not significant in multivariate regression; NA not applicable based on univariate regression

^a Continuous varable

^b Tested in a separate model from other comorbidities

Results in bold are statistically significant